Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,207 | 127 | 94.3% |
| Education | $252.25 | 4 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Journey Medical Corporation | $774.85 | 15 | $0 (2022) |
| ABBVIE INC. | $596.78 | 17 | $0 (2024) |
| Dermavant Sciences, Inc. | $556.06 | 14 | $0 (2024) |
| Galderma Laboratories, L.P. | $514.59 | 26 | $0 (2024) |
| Incyte Corporation | $270.33 | 6 | $0 (2024) |
| GENZYME CORPORATION | $255.11 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $246.22 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $207.92 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $194.88 | 12 | $0 (2021) |
| VYNE Pharmaceuticals Inc. | $182.97 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,210 | 33 | Dermavant Sciences, Inc. ($450.51) |
| 2023 | $539.38 | 19 | ABBVIE INC. ($239.95) |
| 2022 | $1,446 | 42 | Journey Medical Corporation ($558.18) |
| 2021 | $1,264 | 37 | Galderma Laboratories, L.P. ($254.37) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.81 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.48 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.85 | General |
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $83.81 | General |
| 11/15/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $8.52 | General |
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Education | In-kind items and services | $72.00 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $143.32 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.08 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: DERMATOLOGY | ||||||
| 10/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $118.12 | General |
| Category: DERMATOLOGY | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: Immunology | ||||||
| 10/11/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $7.95 | General |
| 10/09/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: DERMATOLOGY | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.03 | General |
| Category: Immunology | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.82 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: DERMATOLOGY | ||||||
| 09/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $120.83 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $142.88 | General |
| 09/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: DERMATOLOGY | ||||||
| 08/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $14.43 | General |
| Category: Dermatology | ||||||
| 08/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $51.24 | General |
| Category: DERMATOLOGY | ||||||
| 08/13/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $82.02 | General |
| Category: DERMATOLOGY | ||||||
| 07/24/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $25.49 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 313 | 664 | $52,654 | $18,725 |
| 2022 | 7 | 219 | 460 | $29,434 | $10,760 |
| 2021 | 6 | 200 | 381 | $24,051 | $11,359 |
| 2020 | 16 | 1,675 | 4,006 | $241,874 | $87,653 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 49 | 72 | $11,749 | $4,567 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 68 | $9,027 | $3,304 | 36.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $7,070 | $2,739 | 38.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 61 | 75 | $7,496 | $2,111 | 28.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 34 | 39 | $5,751 | $1,962 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 22 | $4,126 | $1,811 | 43.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 44 | 334 | $4,725 | $1,256 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,709 | $974.40 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 49 | $4,954 | $2,626 | 53.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 28 | 35 | $4,390 | $1,751 | 39.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 41 | 53 | $5,268 | $1,548 | 29.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 40 | 40 | $5,972 | $1,470 | 24.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 25 | 28 | $3,279 | $1,385 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 16 | $2,300 | $1,103 | 47.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 30 | 239 | $3,271 | $879.11 | 26.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 48 | $5,017 | $2,821 | 56.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 29 | 39 | $4,870 | $2,774 | 57.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 42 | 42 | $5,297 | $2,377 | 44.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 24 | 25 | $2,860 | $1,442 | 50.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 35 | 42 | $3,470 | $1,274 | 36.7% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 28 | 185 | $2,536 | $671.06 | 26.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 274 | 310 | $49,328 | $17,514 | 35.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 270 | 379 | $41,496 | $15,506 | 37.4% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 177 | 229 | $36,815 | $14,633 | 39.7% |
| 17000 | Destruction of skin growth | Office | 2020 | 324 | 414 | $39,257 | $12,501 | 31.8% |
About Arica Edwards
Arica Edwards is a Physician Assistant healthcare provider based in Springfield, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2015. The National Provider Identifier (NPI) number assigned to this provider is 1831564400.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Arica Edwards has received a total of $4,459 in payments from pharmaceutical and medical device companies, with $1,210 received in 2024. These payments were reported across 131 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,207).
As a Medicare-enrolled provider, Edwards has provided services to 2,407 Medicare beneficiaries, totaling 5,511 services with total Medicare billing of $128,498. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Springfield, OH
- Active Since 12/08/2015
- Last Updated 10/14/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1831564400
Products in Payments
- VTAMA (Drug) $556.06
- TREMFYA (Drug) $345.51
- OPZELURA (Drug) $270.33
- RINVOQ (Biological) $258.38
- DUPIXENT (Biological) $237.62
- QBREXZA (Drug) $210.60
- Sotyktu (Drug) $207.92
- AKLIEF (Drug) $200.01
- ZILXI (Drug) $169.59
- EPSOLAY (Drug) $155.87
- Otezla (Drug) $132.13
- LIBTAYO (Biological) $120.83
- SKYRIZI (Biological) $116.00
- EPIDUO FORTE (Drug) $89.72
- CIBINQO (Drug) $77.35
- BOTOX (Biological) $66.76
- REMICADE (Biological) $29.90
- ORACEA (Drug) $28.93
- Neo-Synalar (Drug) $19.40
- Zoryve (Drug) $19.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Springfield
Stacey Panasci, Pa-C, PA-C
Physician Assistant — Payments: $81,487
Cecilia Ross, Pa-C, PA-C
Physician Assistant — Payments: $27,340
Marc Reitzner, P.a, P.A
Physician Assistant — Payments: $18,506
Ms. Kerri St. George, Pa, PA
Physician Assistant — Payments: $14,720
Miss. Morgan Kuhn, Pa-C, PA-C
Physician Assistant — Payments: $12,613
Catherine Earl, Pa-C, PA-C
Physician Assistant — Payments: $11,951